Emerging infectious diseases, 2005-01, Vol.11 (1), p.141-145
2005
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Distribution and characteristics of Escherichia coli clonal group A
- Ist Teil von
- Emerging infectious diseases, 2005-01, Vol.11 (1), p.141-145
- Ort / Verlag
- United States: U.S. National Center for Infectious Diseases
- Erscheinungsjahr
- 2005
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Among 1,102 recent Escherichia coli clinical isolates, clonal group A was identified in 17 of 20 (U.S. and non-U.S.) geographic locales, mainly among U.S. isolates (9% vs. 3%; p < 0.001) and those resistant to trimethoprim-sulfamethoxazole (10% vs. 1.7%; p < 0.001). The extensive antimicrobial resistance and virulence profiles of clonal group A may underlie its recent widespread emergence.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1080-6040eISSN: 1080-6059DOI: 10.3201/eid1101.040418Titel-ID: cdi_doaj_primary_oai_doaj_org_article_02aa266f2196401ea8f6cb783e575dde
- Format
- –
- Schlagworte
- Anti-Infective Agents - pharmacology, antimicrobial resistance, Child, Communicable Diseases, Emerging - epidemiology, Communicable Diseases, Emerging - microbiology, Development and progression, Diagnosis, Drug Resistance, Bacterial, Escherichia coli, Escherichia coli - classification, Escherichia coli - drug effects, Escherichia coli - genetics, Escherichia coli - pathogenicity, Escherichia coli infections, Escherichia coli Infections - epidemiology, Escherichia coli Infections - microbiology, Female, Gram-negative bacterial infections, Humans, Male, Microbial Sensitivity Tests, Phylogeny, Prevalence, Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology, United States - epidemiology, urinary tract infection, Urinary Tract Infections - epidemiology, Urinary Tract Infections - microbiology, Virulence, virulence factors